BTIG sees 'murky' road ahead for cannabis reclassification
https://seekingalpha.com/news/4100037-btig-sees-murky-road-ahead-for-cannabis-reclassification?source=feed_sector_healthcare
May 04, 2024 - BTIG says the road to reclassifying cannabis as a less dangerous substance remains murky, with the process likely getting bogged down for years by legal delays. Read more here.
0
Elon Musk Says Tesla Is Discussing Licensing Self-Driving Technology With "One Major Automaker." Here's Who I Think It Is and Why I See Tesla Stock as the Better Buy.
https://www.fool.com/investing/2024/05/06/elon-musk-says-tesla-is-discussing-licensing-self/?source=iedfolrf0000001
May 06, 2024 - During Tesla's first-quarter earnings call, investors learned that the company is exploring licensing opportunities in autonomous driving.
0
Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High?
https://www.zacks.com/stock/news/2268786/wall-street-analysts-see-a-56-11-upside-in-pulmonx-lung-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2268786
May 06, 2024 - The consensus price target hints at a 56.1% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
0
Silgan (SLGN) Q1 Earnings Beat Estimates, Revenues Dip Y/Y
https://www.zacks.com/stock/news/2269028/silgan-slgn-q1-earnings-beat-estimates-revenues-dip-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2269028
May 06, 2024 - Silgan's (SLGN) first-quarter top and bottom lines reflect the impacts of lower volumes owing to customer destocking.
0
Camtek Q1 Results Climb, Beat Estimates; Sees Higher Q2 Revenues; Stock Up In Pre-market
https://www.rttnews.com/story.aspx?Id=3446548
May 09, 2024 - Camtek Ltd. (CAMT), a semiconductor equipment manufacturer, reported Thursday that its first-quarter net income totaled $24.8 million or $0.51 per share, an increase of 21 percent from last year's $17.2 million or $0.36 per share.
0
U.S. Stocks May See Further Upside In Early Trading
https://www.rttnews.com/story.aspx?Id=3447042
May 10, 2024 - Stocks are likely to move to the upside in early trading on Friday, extending the advance seen over the course of the previous session. The major index futures are currently pointing to a higher open for the markets, with the S&P 500 futures up by 0.3 percent.
0
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2272107/wall-street-analysts-see-tenet-thc-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2272107
May 10, 2024 - According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0
Parent of CycleBar, Pure Barre fitness studios sees shares whipsaw after CEO ousted, federal probe disclosed
https://www.cnbc.com/2024/05/13/xponential-fitness-sees-stock-whipsaw-after-ceo-ousted.html
May 13, 2024 - The parent company of CycleBar and Pure Barre studios said CEO Anthony Geisler would be suspended indefinitely and also disclosed a federal investigation.
0
Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA
https://seekingalpha.com/news/4105409-avadel-gains-for-a-second-day-as-analysts-see-it-prevailing-in-case-vs-jazzfda?source=feed_sector_healthcare
May 13, 2024 - Avadel Pharmaceuticals (AVDL) gains 17% after hearing on dispute over FDA approval for sleep disorder drug amidst patent conflict with Jazz Pharmaceuticals...
0
U.S. Stocks Seeing Modest Strength, Dow Higher For Ninth Straight Session
https://www.rttnews.com/story.aspx?Id=3447394
May 13, 2024 - Stocks have moved modestly higher during trading on Monday, adding to the strong gains posted last week. The major averages have all moved to the upside on the day, although buying interest has remained somewhat subdued. The modest strength on Wall Street comes as stocks continue to benefit from recent upward momentum, which has led to an eight-day winning streak for the Dow.
0